Treatment of acute leukemia.
D001215:Asparaginase / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004357:Drug Synergism; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008938:Mitosis / Q000187:drug effects; D009380:Neoplasms, Nerve Tissue / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013736:Testicular Neoplasms / Q000532:radiotherapy / Q000601:surgery; D014527:Uric Acid / Q000652:urine; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014527:Uric Acid; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin